nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Organic cation transport—SLC22A18—breast cancer	0.0125	0.0902	CbGpPWpGaD
Cefadroxil—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.00848	0.0612	CbGpPWpGaD
Cefadroxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.00767	0.0553	CbGpPWpGaD
Cefadroxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.0064	0.0462	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.0025	0.018	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00232	0.0167	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00224	0.0162	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00203	0.0146	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00186	0.0134	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.0017	0.0123	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00169	0.0122	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00168	0.0121	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00163	0.0118	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00154	0.0111	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00148	0.0107	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00141	0.0102	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.0014	0.0101	CbGpPWpGaD
Cefadroxil—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.00128	0.00927	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00128	0.00925	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00127	0.00919	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00123	0.00891	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00122	0.0088	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.00119	0.0086	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00113	0.00817	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00112	0.00805	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00112	0.00805	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00111	0.00804	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00106	0.00767	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00104	0.00747	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00104	0.00747	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00102	0.00735	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00102	0.00735	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00101	0.00727	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000924	0.00667	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000921	0.00665	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000921	0.00665	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000858	0.00619	CbGpPWpGaD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000846	0.00611	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000845	0.0061	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000844	0.00609	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00084	0.00607	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000814	0.00587	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000814	0.00587	CbGpPWpGaD
Cefadroxil—Cefpiramide—ALB—breast cancer	0.000791	0.19	CrCbGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000784	0.00566	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000772	0.00557	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000768	0.00555	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000768	0.00555	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000765	0.00553	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000763	0.00551	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000756	0.00546	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000755	0.00545	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000755	0.00545	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000743	0.00536	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000743	0.00536	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000702	0.00507	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.0007	0.00506	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000698	0.00504	CbGpPWpGaD
Cefadroxil—Cefonicid—ALB—breast cancer	0.000689	0.165	CrCbGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000672	0.00485	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000672	0.00485	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.00065	0.00469	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000639	0.00462	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000639	0.00461	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000637	0.0046	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00062	0.00447	CbGpPWpGaD
Cefadroxil—Eosinophilia—Methotrexate—breast cancer	0.000584	0.000685	CcSEcCtD
Cefadroxil—Nausea—Vinblastine—breast cancer	0.000584	0.000684	CcSEcCtD
Cefadroxil—Somnolence—Gemcitabine—breast cancer	0.000583	0.000684	CcSEcCtD
Cefadroxil—Convulsion—Paclitaxel—breast cancer	0.000583	0.000683	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000582	0.0042	CbGpPWpGaD
Cefadroxil—Gastrointestinal disorder—Irinotecan—breast cancer	0.000582	0.000682	CcSEcCtD
Cefadroxil—Vomiting—Goserelin—breast cancer	0.00058	0.00068	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000578	0.00417	CbGpPWpGaD
Cefadroxil—Pruritus—Vinorelbine—breast cancer	0.000578	0.000677	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000576	0.000674	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000576	0.000674	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000575	0.00415	CbGpPWpGaD
Cefadroxil—Rash—Goserelin—breast cancer	0.000575	0.000674	CcSEcCtD
Cefadroxil—Hypersensitivity—Thiotepa—breast cancer	0.000575	0.000673	CcSEcCtD
Cefadroxil—Dermatitis—Goserelin—breast cancer	0.000575	0.000673	CcSEcCtD
Cefadroxil—Somnolence—Fluorouracil—breast cancer	0.000574	0.000672	CcSEcCtD
Cefadroxil—Arthralgia—Paclitaxel—breast cancer	0.000573	0.000672	CcSEcCtD
Cefadroxil—Headache—Goserelin—breast cancer	0.000571	0.00067	CcSEcCtD
Cefadroxil—Dyspepsia—Fluorouracil—breast cancer	0.000568	0.000666	CcSEcCtD
Cefadroxil—Nausea—Tamoxifen—breast cancer	0.000567	0.000665	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000567	0.00409	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000567	0.00409	CbGpPWpGaD
Cefadroxil—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000567	0.000664	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000566	0.00408	CbGpPWpGaD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000564	0.000661	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000561	0.00405	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000561	0.00405	CbGpPWpGaD
Cefadroxil—Pancytopenia—Methotrexate—breast cancer	0.000561	0.000657	CcSEcCtD
Cefadroxil—Asthenia—Thiotepa—breast cancer	0.00056	0.000656	CcSEcCtD
Cefadroxil—Diarrhoea—Vinorelbine—breast cancer	0.000559	0.000655	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000557	0.000653	CcSEcCtD
Cefadroxil—Nausea—Melphalan—breast cancer	0.000555	0.000651	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—breast cancer	0.000554	0.000649	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—breast cancer	0.000552	0.000647	CcSEcCtD
Cefadroxil—Pruritus—Thiotepa—breast cancer	0.000552	0.000647	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000551	0.000646	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Irinotecan—breast cancer	0.000551	0.000646	CcSEcCtD
Cefadroxil—Anaphylactic shock—Paclitaxel—breast cancer	0.000549	0.000644	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—breast cancer	0.000549	0.000643	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—breast cancer	0.000547	0.000641	CcSEcCtD
Cefadroxil—Nausea—Goserelin—breast cancer	0.000542	0.000635	CcSEcCtD
Cefadroxil—Dizziness—Vinorelbine—breast cancer	0.00054	0.000633	CcSEcCtD
Cefadroxil—Thrombocytopenia—Paclitaxel—breast cancer	0.000538	0.00063	CcSEcCtD
Cefadroxil—Urticaria—Mitoxantrone—breast cancer	0.000535	0.000627	CcSEcCtD
Cefadroxil—Diarrhoea—Thiotepa—breast cancer	0.000534	0.000625	CcSEcCtD
Cefadroxil—Body temperature increased—Mitoxantrone—breast cancer	0.000533	0.000624	CcSEcCtD
Cefadroxil—Body temperature increased—Irinotecan—breast cancer	0.000533	0.000624	CcSEcCtD
Cefadroxil—Abdominal pain—Irinotecan—breast cancer	0.000533	0.000624	CcSEcCtD
Cefadroxil—Abdominal pain—Mitoxantrone—breast cancer	0.000533	0.000624	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.000532	0.000624	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000532	0.000624	CcSEcCtD
Cefadroxil—Muscle spasms—Capecitabine—breast cancer	0.000531	0.000622	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—breast cancer	0.000526	0.000617	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000526	0.0038	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000526	0.0038	CbGpPWpGaD
Cefadroxil—Pancytopenia—Epirubicin—breast cancer	0.000525	0.000615	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000522	0.000611	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.000522	0.000611	CcSEcCtD
Cefadroxil—Vomiting—Vinorelbine—breast cancer	0.000519	0.000609	CcSEcCtD
Cefadroxil—Body temperature increased—Gemcitabine—breast cancer	0.000519	0.000608	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000517	0.00373	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000517	0.00373	CbGpPWpGaD
Cefadroxil—Neutropenia—Epirubicin—breast cancer	0.000517	0.000605	CcSEcCtD
Cefadroxil—Dizziness—Thiotepa—breast cancer	0.000516	0.000604	CcSEcCtD
Cefadroxil—Rash—Vinorelbine—breast cancer	0.000515	0.000604	CcSEcCtD
Cefadroxil—Dermatitis—Vinorelbine—breast cancer	0.000515	0.000603	CcSEcCtD
Cefadroxil—Urticaria—Fluorouracil—breast cancer	0.000513	0.000601	CcSEcCtD
Cefadroxil—Headache—Vinorelbine—breast cancer	0.000512	0.0006	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000512	0.00369	CbGpPWpGaD
Cefadroxil—Body temperature increased—Fluorouracil—breast cancer	0.00051	0.000598	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—breast cancer	0.000506	0.000593	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000501	0.000587	CcSEcCtD
Cefadroxil—Vertigo—Capecitabine—breast cancer	0.000496	0.000582	CcSEcCtD
Cefadroxil—Hypersensitivity—Irinotecan—breast cancer	0.000496	0.000582	CcSEcCtD
Cefadroxil—Hypersensitivity—Mitoxantrone—breast cancer	0.000496	0.000582	CcSEcCtD
Cefadroxil—Vomiting—Thiotepa—breast cancer	0.000496	0.000581	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—breast cancer	0.000494	0.000579	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—breast cancer	0.000493	0.000577	CcSEcCtD
Cefadroxil—Rash—Thiotepa—breast cancer	0.000492	0.000576	CcSEcCtD
Cefadroxil—Dermatitis—Thiotepa—breast cancer	0.000491	0.000576	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—breast cancer	0.000491	0.000575	CcSEcCtD
Cefadroxil—Headache—Thiotepa—breast cancer	0.000489	0.000573	CcSEcCtD
Cefadroxil—Somnolence—Paclitaxel—breast cancer	0.000488	0.000572	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000488	0.000572	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—breast cancer	0.000486	0.000569	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—breast cancer	0.000485	0.000569	CcSEcCtD
Cefadroxil—Nausea—Vinorelbine—breast cancer	0.000485	0.000569	CcSEcCtD
Cefadroxil—Dyspepsia—Paclitaxel—breast cancer	0.000484	0.000567	CcSEcCtD
Cefadroxil—Asthenia—Mitoxantrone—breast cancer	0.000483	0.000566	CcSEcCtD
Cefadroxil—Asthenia—Irinotecan—breast cancer	0.000483	0.000566	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000483	0.00348	CbGpPWpGaD
Cefadroxil—Neutropenia—Doxorubicin—breast cancer	0.000478	0.00056	CcSEcCtD
Cefadroxil—Hypersensitivity—Fluorouracil—breast cancer	0.000475	0.000557	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—breast cancer	0.000475	0.000556	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000474	0.000556	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—breast cancer	0.000472	0.000554	CcSEcCtD
Cefadroxil—Asthenia—Gemcitabine—breast cancer	0.000471	0.000552	CcSEcCtD
Cefadroxil—Arthralgia—Capecitabine—breast cancer	0.00047	0.000551	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.00047	0.00339	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00047	0.00339	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000468	0.00338	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000468	0.00338	CbGpPWpGaD
Cefadroxil—Anaphylactic shock—Docetaxel—breast cancer	0.000466	0.000546	CcSEcCtD
Cefadroxil—Pruritus—Gemcitabine—breast cancer	0.000464	0.000544	CcSEcCtD
Cefadroxil—Nausea—Thiotepa—breast cancer	0.000463	0.000543	CcSEcCtD
Cefadroxil—Diarrhoea—Mitoxantrone—breast cancer	0.000461	0.00054	CcSEcCtD
Cefadroxil—Diarrhoea—Irinotecan—breast cancer	0.000461	0.00054	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—breast cancer	0.00046	0.000539	CcSEcCtD
Cefadroxil—Pruritus—Fluorouracil—breast cancer	0.000456	0.000535	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—breast cancer	0.000456	0.000534	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—breast cancer	0.000456	0.000534	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000452	0.000529	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Paclitaxel—breast cancer	0.000449	0.000526	CcSEcCtD
Cefadroxil—Diarrhoea—Gemcitabine—breast cancer	0.000449	0.000526	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—breast cancer	0.000447	0.000523	CcSEcCtD
Cefadroxil—Cefradine—CYP3A4—breast cancer	0.000446	0.107	CrCbGaD
Cefadroxil—Dizziness—Irinotecan—breast cancer	0.000445	0.000522	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—breast cancer	0.000444	0.000521	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—breast cancer	0.000442	0.000518	CcSEcCtD
Cefadroxil—Diarrhoea—Fluorouracil—breast cancer	0.000441	0.000517	CcSEcCtD
Cefadroxil—Thrombocytopenia—Capecitabine—breast cancer	0.000441	0.000517	CcSEcCtD
Cefadroxil—Urticaria—Paclitaxel—breast cancer	0.000436	0.000511	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000436	0.00315	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000436	0.00315	CbGpPWpGaD
Cefadroxil—Body temperature increased—Paclitaxel—breast cancer	0.000434	0.000509	CcSEcCtD
Cefadroxil—Abdominal pain—Paclitaxel—breast cancer	0.000434	0.000509	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.00043	0.0031	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000429	0.00309	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—COX11—breast cancer	0.000429	0.00309	CbGpPWpGaD
Cefadroxil—Vomiting—Mitoxantrone—breast cancer	0.000428	0.000502	CcSEcCtD
Cefadroxil—Vomiting—Irinotecan—breast cancer	0.000428	0.000502	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000427	0.00308	CbGpPWpGaD
Cefadroxil—Dizziness—Fluorouracil—breast cancer	0.000427	0.0005	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—breast cancer	0.000425	0.000498	CcSEcCtD
Cefadroxil—Rash—Mitoxantrone—breast cancer	0.000425	0.000498	CcSEcCtD
Cefadroxil—Rash—Irinotecan—breast cancer	0.000425	0.000498	CcSEcCtD
Cefadroxil—Dermatitis—Mitoxantrone—breast cancer	0.000424	0.000497	CcSEcCtD
Cefadroxil—Dermatitis—Irinotecan—breast cancer	0.000424	0.000497	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000424	0.000497	CcSEcCtD
Cefadroxil—Headache—Mitoxantrone—breast cancer	0.000422	0.000495	CcSEcCtD
Cefadroxil—Headache—Irinotecan—breast cancer	0.000422	0.000495	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000421	0.00304	CbGpPWpGaD
Cefadroxil—Erythema multiforme—Epirubicin—breast cancer	0.000418	0.00049	CcSEcCtD
Cefadroxil—Vomiting—Gemcitabine—breast cancer	0.000417	0.000489	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—breast cancer	0.000414	0.000485	CcSEcCtD
Cefadroxil—Rash—Gemcitabine—breast cancer	0.000414	0.000485	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000413	0.00299	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000413	0.00299	CbGpPWpGaD
Cefadroxil—Dermatitis—Gemcitabine—breast cancer	0.000413	0.000484	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—breast cancer	0.000411	0.000482	CcSEcCtD
Cefadroxil—Headache—Gemcitabine—breast cancer	0.000411	0.000482	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000411	0.000481	CcSEcCtD
Cefadroxil—Vomiting—Fluorouracil—breast cancer	0.00041	0.000481	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—breast cancer	0.00041	0.00048	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—breast cancer	0.000409	0.000479	CcSEcCtD
Cefadroxil—Rash—Fluorouracil—breast cancer	0.000407	0.000477	CcSEcCtD
Cefadroxil—Dermatitis—Fluorouracil—breast cancer	0.000406	0.000476	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—breast cancer	0.000406	0.0975	CrCbGaD
Cefadroxil—Hypersensitivity—Paclitaxel—breast cancer	0.000405	0.000474	CcSEcCtD
Cefadroxil—Headache—Fluorouracil—breast cancer	0.000404	0.000474	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—breast cancer	0.000402	0.000471	CcSEcCtD
Cefadroxil—Nausea—Mitoxantrone—breast cancer	0.0004	0.000469	CcSEcCtD
Cefadroxil—Nausea—Irinotecan—breast cancer	0.0004	0.000469	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000399	0.00288	CbGpPWpGaD
Cefadroxil—Dyspepsia—Capecitabine—breast cancer	0.000397	0.000465	CcSEcCtD
Cefadroxil—Asthenia—Paclitaxel—breast cancer	0.000394	0.000462	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000392	0.00283	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000391	0.00282	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00039	0.00282	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00039	0.00282	CbGpPWpGaD
Cefadroxil—Nausea—Gemcitabine—breast cancer	0.00039	0.000457	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Capecitabine—breast cancer	0.000389	0.000456	CcSEcCtD
Cefadroxil—Pruritus—Paclitaxel—breast cancer	0.000389	0.000455	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—COX11—breast cancer	0.000388	0.0028	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000388	0.0028	CbGpPWpGaD
Cefadroxil—Erythema multiforme—Doxorubicin—breast cancer	0.000387	0.000453	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000385	0.00278	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000384	0.00277	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000384	0.00277	CbGpPWpGaD
Cefadroxil—Nausea—Fluorouracil—breast cancer	0.000383	0.000449	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Docetaxel—breast cancer	0.000381	0.000446	CcSEcCtD
Cefadroxil—Tension—Epirubicin—breast cancer	0.000378	0.000443	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000377	0.00272	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000377	0.00272	CbGpPWpGaD
Cefadroxil—Diarrhoea—Paclitaxel—breast cancer	0.000376	0.000441	CcSEcCtD
Cefadroxil—SLC15A2—mammary gland—breast cancer	0.000374	0.0952	CbGeAlD
Cefadroxil—Nervousness—Epirubicin—breast cancer	0.000374	0.000438	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—breast cancer	0.00037	0.000434	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—breast cancer	0.00037	0.000433	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Capecitabine—breast cancer	0.000369	0.000432	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—breast cancer	0.000368	0.000431	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—breast cancer	0.000368	0.000431	CcSEcCtD
Cefadroxil—Dizziness—Paclitaxel—breast cancer	0.000363	0.000426	CcSEcCtD
Cefadroxil—Urticaria—Capecitabine—breast cancer	0.000358	0.00042	CcSEcCtD
Cefadroxil—Body temperature increased—Capecitabine—breast cancer	0.000356	0.000418	CcSEcCtD
Cefadroxil—Abdominal pain—Capecitabine—breast cancer	0.000356	0.000418	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—breast cancer	0.000356	0.000418	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000356	0.00257	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000355	0.00256	CbGpPWpGaD
Cefadroxil—Arthralgia—Methotrexate—breast cancer	0.00035	0.00041	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—breast cancer	0.000349	0.000409	CcSEcCtD
Cefadroxil—Vomiting—Paclitaxel—breast cancer	0.000349	0.000409	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000348	0.00251	CbGpPWpGaD
Cefadroxil—Rash—Paclitaxel—breast cancer	0.000346	0.000406	CcSEcCtD
Cefadroxil—Dermatitis—Paclitaxel—breast cancer	0.000346	0.000406	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—breast cancer	0.000346	0.000405	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—breast cancer	0.000346	0.000405	CcSEcCtD
Cefadroxil—Ampicillin—ALB—breast cancer	0.000345	0.0829	CrCbGaD
Cefadroxil—Headache—Paclitaxel—breast cancer	0.000344	0.000403	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—breast cancer	0.000343	0.000402	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—breast cancer	0.000342	0.000401	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000341	0.00246	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000341	0.00246	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000338	0.00244	CbGpPWpGaD
Cefadroxil—Cephalexin—CYP2D6—breast cancer	0.000337	0.0808	CrCbGaD
Cefadroxil—Anaphylactic shock—Methotrexate—breast cancer	0.000336	0.000393	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—breast cancer	0.000334	0.000392	CcSEcCtD
Cefadroxil—Cefazolin—ALB—breast cancer	0.000334	0.0801	CrCbGaD
Cefadroxil—Convulsion—Epirubicin—breast cancer	0.000333	0.000391	CcSEcCtD
Cefadroxil—SLC15A1—epithelium—breast cancer	0.000333	0.0848	CbGeAlD
Cefadroxil—Hypersensitivity—Capecitabine—breast cancer	0.000332	0.000389	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.00033	0.00238	CbGpPWpGaD
Cefadroxil—Pruritus—Docetaxel—breast cancer	0.000329	0.000386	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—breast cancer	0.000329	0.000385	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—breast cancer	0.000328	0.000384	CcSEcCtD
Cefadroxil—Nausea—Paclitaxel—breast cancer	0.000326	0.000382	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000326	0.00236	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000326	0.00235	CbGpPWpGaD
Cefadroxil—SLC22A5—mammary gland—breast cancer	0.000325	0.0828	CbGeAlD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000325	0.00235	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000324	0.00234	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000324	0.00234	CbGpPWpGaD
Cefadroxil—Asthenia—Capecitabine—breast cancer	0.000323	0.000379	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—breast cancer	0.00032	0.000375	CcSEcCtD
Cefadroxil—Pruritus—Capecitabine—breast cancer	0.000319	0.000374	CcSEcCtD
Cefadroxil—Diarrhoea—Docetaxel—breast cancer	0.000319	0.000373	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—breast cancer	0.000314	0.000368	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000314	0.00226	CbGpPWpGaD
Cefadroxil—Convulsion—Doxorubicin—breast cancer	0.000309	0.000362	CcSEcCtD
Cefadroxil—Diarrhoea—Capecitabine—breast cancer	0.000308	0.000361	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000308	0.00223	CbGpPWpGaD
Cefadroxil—Dizziness—Docetaxel—breast cancer	0.000308	0.000361	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—breast cancer	0.000308	0.00036	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000306	0.000358	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—breast cancer	0.000303	0.000355	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000303	0.00219	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000303	0.00218	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000302	0.00218	CbGpPWpGaD
Cefadroxil—SLC15A1—endometrium—breast cancer	0.000299	0.076	CbGeAlD
Cefadroxil—Somnolence—Methotrexate—breast cancer	0.000298	0.00035	CcSEcCtD
Cefadroxil—Dizziness—Capecitabine—breast cancer	0.000298	0.000349	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000298	0.00215	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000297	0.00215	CbGpPWpGaD
Cefadroxil—Vomiting—Docetaxel—breast cancer	0.000296	0.000347	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000296	0.00214	CbGpPWpGaD
Cefadroxil—Dyspepsia—Methotrexate—breast cancer	0.000295	0.000346	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000294	0.00212	CbGpPWpGaD
Cefadroxil—Rash—Docetaxel—breast cancer	0.000294	0.000344	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—breast cancer	0.000293	0.000344	CcSEcCtD
Cefadroxil—Headache—Docetaxel—breast cancer	0.000292	0.000342	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—breast cancer	0.000291	0.000341	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00029	0.0021	CbGpPWpGaD
Cefadroxil—Gastrointestinal disorder—Methotrexate—breast cancer	0.00029	0.00034	CcSEcCtD
Cefadroxil—Cephalexin—CYP3A4—breast cancer	0.000289	0.0693	CrCbGaD
Cefadroxil—Vomiting—Capecitabine—breast cancer	0.000287	0.000336	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000286	0.000335	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000285	0.00206	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000285	0.00206	CbGpPWpGaD
Cefadroxil—Thrombocytopenia—Doxorubicin—breast cancer	0.000285	0.000333	CcSEcCtD
Cefadroxil—Rash—Capecitabine—breast cancer	0.000284	0.000333	CcSEcCtD
Cefadroxil—Dermatitis—Capecitabine—breast cancer	0.000284	0.000333	CcSEcCtD
Cefadroxil—Headache—Capecitabine—breast cancer	0.000282	0.000331	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000281	0.00203	CbGpPWpGaD
Cefadroxil—Somnolence—Epirubicin—breast cancer	0.000279	0.000327	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000279	0.00201	CbGpPWpGaD
Cefadroxil—Cefalotin—ALB—breast cancer	0.000277	0.0665	CrCbGaD
Cefadroxil—Nausea—Docetaxel—breast cancer	0.000277	0.000324	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—breast cancer	0.000276	0.000324	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000276	0.00199	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Methotrexate—breast cancer	0.000274	0.000322	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—breast cancer	0.000271	0.000318	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000269	0.00194	CbGpPWpGaD
Cefadroxil—SLC22A5—nipple—breast cancer	0.000269	0.0685	CbGeAlD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000269	0.00194	CbGpPWpGaD
Cefadroxil—Nausea—Capecitabine—breast cancer	0.000268	0.000314	CcSEcCtD
Cefadroxil—Urticaria—Methotrexate—breast cancer	0.000267	0.000312	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—breast cancer	0.000265	0.000311	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—breast cancer	0.000265	0.000311	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000265	0.00031	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—breast cancer	0.000258	0.000303	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000257	0.00186	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Epirubicin—breast cancer	0.000257	0.000301	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—breast cancer	0.000256	0.0003	CcSEcCtD
Cefadroxil—Cephalexin—ALB—breast cancer	0.000252	0.0604	CrCbGaD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000251	0.000294	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00025	0.0018	CbGpPWpGaD
Cefadroxil—Urticaria—Epirubicin—breast cancer	0.00025	0.000292	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—breast cancer	0.000248	0.000291	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—breast cancer	0.000248	0.000291	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—breast cancer	0.000247	0.00029	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000245	0.00177	CbGpPWpGaD
Cefadroxil—Asthenia—Methotrexate—breast cancer	0.000241	0.000282	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000239	0.00172	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Doxorubicin—breast cancer	0.000238	0.000278	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—breast cancer	0.000237	0.000278	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000235	0.0017	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000233	0.00168	CbGpPWpGaD
Cefadroxil—Hypersensitivity—Epirubicin—breast cancer	0.000231	0.000271	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—breast cancer	0.000231	0.000271	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—breast cancer	0.00023	0.000269	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—breast cancer	0.00023	0.000269	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—breast cancer	0.00023	0.000269	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—breast cancer	0.000225	0.000264	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000225	0.00162	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000224	0.00162	CbGpPWpGaD
Cefadroxil—Pruritus—Epirubicin—breast cancer	0.000222	0.00026	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—breast cancer	0.000222	0.00026	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—breast cancer	0.000215	0.000252	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—breast cancer	0.000214	0.000251	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000214	0.00155	CbGpPWpGaD
Cefadroxil—Vomiting—Methotrexate—breast cancer	0.000213	0.00025	CcSEcCtD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000212	0.00153	CbGpPWpGaD
Cefadroxil—Rash—Methotrexate—breast cancer	0.000212	0.000248	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—breast cancer	0.000211	0.000248	CcSEcCtD
Cefadroxil—Headache—Methotrexate—breast cancer	0.00021	0.000246	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00021	0.00151	CbGpPWpGaD
Cefadroxil—SLC15A1—endocrine gland—breast cancer	0.000209	0.0533	CbGeAlD
Cefadroxil—Asthenia—Doxorubicin—breast cancer	0.000209	0.000244	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000208	0.00151	CbGpPWpGaD
Cefadroxil—Dizziness—Epirubicin—breast cancer	0.000208	0.000243	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—breast cancer	0.000206	0.000241	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—breast cancer	0.0002	0.000234	CcSEcCtD
Cefadroxil—Nausea—Methotrexate—breast cancer	0.000199	0.000234	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—breast cancer	0.000199	0.000233	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000199	0.00143	CbGpPWpGaD
Cefadroxil—Rash—Epirubicin—breast cancer	0.000198	0.000232	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—breast cancer	0.000198	0.000232	CcSEcCtD
Cefadroxil—Headache—Epirubicin—breast cancer	0.000197	0.000231	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000195	0.00141	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000195	0.00141	CbGpPWpGaD
Cefadroxil—Dizziness—Doxorubicin—breast cancer	0.000192	0.000225	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000191	0.00138	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000187	0.00135	CbGpPWpGaD
Cefadroxil—SLC15A2—endometrium—breast cancer	0.000187	0.0475	CbGeAlD
Cefadroxil—Nausea—Epirubicin—breast cancer	0.000187	0.000219	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—breast cancer	0.000185	0.000217	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—breast cancer	0.000183	0.000215	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—breast cancer	0.000183	0.000215	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—breast cancer	0.000182	0.000213	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00018	0.0013	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000177	0.00128	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000177	0.00128	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000174	0.00125	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000173	0.00125	CbGpPWpGaD
Cefadroxil—Nausea—Doxorubicin—breast cancer	0.000173	0.000202	CcSEcCtD
Cefadroxil—SLC22A5—skin of body—breast cancer	0.000172	0.0439	CbGeAlD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000172	0.00124	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—TFRC—breast cancer	0.000171	0.00123	CbGpPWpGaD
Cefadroxil—SLC15A2—pituitary gland—breast cancer	0.000169	0.043	CbGeAlD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000167	0.00121	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000166	0.0012	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000164	0.00119	CbGpPWpGaD
Cefadroxil—SLC22A5—endometrium—breast cancer	0.000162	0.0413	CbGeAlD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000161	0.00116	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000159	0.00115	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000157	0.00113	CbGpPWpGaD
Cefadroxil—SLC15A2—female reproductive system—breast cancer	0.000155	0.0394	CbGeAlD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	0.000154	0.00111	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000154	0.00111	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000152	0.00109	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000151	0.00109	CbGpPWpGaD
Cefadroxil—SLC15A2—adrenal gland—breast cancer	0.000151	0.0384	CbGeAlD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.00015	0.00108	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000149	0.00107	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000148	0.00107	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000148	0.00106	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	0.000147	0.00106	CbGpPWpGaD
Cefadroxil—SLC22A5—pituitary gland—breast cancer	0.000147	0.0374	CbGeAlD
Cefadroxil—SLC22A5—adipose tissue—breast cancer	0.000146	0.0373	CbGeAlD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000145	0.00104	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000142	0.00102	CbGpPWpGaD
Cefadroxil—SLC15A2—female gonad—breast cancer	0.000141	0.0358	CbGeAlD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000141	0.00102	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000138	0.000999	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000137	0.00099	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000137	0.000988	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000136	0.000985	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	0.000135	0.000974	CbGpPWpGaD
Cefadroxil—SLC22A5—female reproductive system—breast cancer	0.000135	0.0342	CbGeAlD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	0.000133	0.00096	CbGpPWpGaD
Cefadroxil—SLC22A5—adrenal gland—breast cancer	0.000131	0.0334	CbGeAlD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000131	0.000945	CbGpPWpGaD
Cefadroxil—SLC15A2—endocrine gland—breast cancer	0.000131	0.0333	CbGeAlD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	0.000129	0.00093	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000127	0.000914	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000125	0.000904	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000124	0.000899	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000124	0.000895	CbGpPWpGaD
Cefadroxil—SLC22A5—female gonad—breast cancer	0.000122	0.0312	CbGeAlD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	0.000122	0.000881	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000122	0.000877	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000119	0.000863	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000118	0.000854	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000114	0.000825	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000113	0.000813	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	0.000111	0.000802	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000108	0.00078	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000104	0.000754	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	0.000102	0.000735	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	9.4e-05	0.000678	CbGpPWpGaD
Cefadroxil—SLC15A2—lymph node—breast cancer	9.05e-05	0.023	CbGeAlD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	9.02e-05	0.000651	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	8.19e-05	0.000591	CbGpPWpGaD
Cefadroxil—SLC22A5—lymph node—breast cancer	7.87e-05	0.02	CbGeAlD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	7.6e-05	0.000549	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	7.48e-05	0.00054	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	7.41e-05	0.000535	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	6.87e-05	0.000496	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	6.76e-05	0.000488	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	6.76e-05	0.000488	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	6.11e-05	0.000441	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	5.64e-05	0.000407	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	5.1e-05	0.000368	CbGpPWpGaD
